"Peripheral neuropathy"

Summary - Cryotherapy for the prevention of taxane-induced peripheral neuropathy Cryotherapy for the prevention of taxane-induced peripheral neuropathy English summary Une production de l’Institut national d’excellence en santé et en services sociaux (INESSS) MARCH 2023 1 SUMMARY Cryotherapy for the prevention of taxane-induced peripheral neuropathy Many solid tumours are treated with chemotherapy drugs, including those in the taxane family. These drugs can have significant adverse effects, especially symptoms of chemotherapy-induced peripheral neuropathy (CIPN). These symptoms manifest as sensory and motor disorders and as pain in the upper and lower limbs. The symptoms are associated with poorer quality of life. The incidence of peripheral

Spinal cord stimulation for adults with chronic chemotherapy-induced peripheral neuropathy AAAReports & Guidance > Spinal cord stimulationSpinal cord stimulationRegister an interest in this topicTOPIC STATUS Complete Spinal cord stimulation for adults with chronic chemotherapy-induced peripheral neuropathy.Summary Health Technology Wales researchers searched for evidence on the clinical effectiveness and cost effectiveness of on the use of spinal cord stimulation for chronic chemotherapy-induced peripheral neuropathy. HTW’s Assessment Group decided not to progress the topic further as there is existing NICE guidance covering the use of this technology for chronic pain of neuropathic origin.Topic Exploration ReportTER460 05.2023TERView PDFHealth Technology Wales PartnersAdjust contrastQuick

Neuropad for screening and detection of early signs of diabetic peripheral neuropathy Neuropad - Health Technology Wales * CymraegX Search * Home * About * Reports & Guidance * Suggest a topic * Digital Open Topic Call 2022 * Impact * News & Events * Scientific Advice Service * COVID-19 * Contact * Home * About * Reports & Guidance * Suggest a topic * Digital Open Topic Call 2022 * Impact * News & Events * Scientific Advice Service * COVID-19 * ContactReports & Guidance > NeuropadNeuropadTopic Status Complete Neuropad for screening and detection of early signs of diabetic peripheral neuropathySummaryHealth Technology Wales researchers searched for evidence on the use of Neuropad for screening and detection of early signs of diabetic peripheral neuropathy. HTW’s Assessment Group decided

Neuropad for detecting preclinical diabetic peripheral neuropathy Neuropad for detecting preclinical diabetic peripheral neuropathy Medical technologies guidance Published: 10 September 2018 www.nice.org.uk/guidance/mtg38 © NICE 2021. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights).Your responsibility Your responsibility with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)© NICE 2021. All rights reserved. Subject to Notice of rights (https

Rituximab for the treatment of IgM paraproteinaemic demyelinating peripheral neuropathy in adults NHS England » Rituximab for the treatment of IgM paraproteinaemic demyelinating peripheral neuropathy in adults Skip to main content Cookies on the NHS England websiteWe’ve put some small files called cookies on your device to make our site work.We’d also like to use analytics cookies. These send * Commissioning * Get involvedOur advice for clinicians on the coronavirus is here.If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.Rituximab for the treatment of IgM paraproteinaemic demyelinating peripheral neuropathy

Exploring the role of mitochondrial-associated and peripheral neuropathy genes in the pathogenesis of diabetic peripheral neuropathy. Diabetic peripheral neuropathy (DPN) is a prevalent and serious complication of diabetes mellitus, impacting the nerves in the limbs and leading to symptoms like pain, numbness, and diminished function. While the exact molecular and immune mechanisms underlying DPN remain incompletely understood, recent findings indicate that mitochondrial dysfunction may play a role in the advancement of this diabetic condition. Two RNA transcriptome datasets (codes: GSE185011 and GSE95849), comprising samples from diabetic peripheral neuropathy (DPN) patients and healthy controls (HC), were retrieved from the Gene Expression Omnibus (GEO) database hosted by the National

A real-world multicenter cross-sectional observational study to assess the clinical profile of peripheral neuropathy in patients with diabetes. There are limited studies on the prevalence of diabetic peripheral neuropathy (DPN) and related foot deformities in patients with T2DM from India. To investigate the prevalence, characteristics, and risk factors for foot deformities in Asian-Indian

Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy. Diabetic peripheral neuropathy (DPN) is a common and severe complication that affects 50% of people with diabetes. Painful DPN is reported to occur in 16% to 24% of people with diabetes. A complete and comprehensive management strategy for the prevention and treatment of DPN, whether painful or not, has not yet been

The accuracy of 10 g monofilament use for clinical screening of diabetes peripheral neuropathy among Indian population. The purpose of this study was to test the diagnostic accuracy of the 10g monofilament to screen for diabetic peripheral neuropathy (DPN) in India. The study further assessed the effect of physical activity, footwear use, and occupation on the outcome. Non-probabilistic

Diagnostic contribution of multi-frequency vibrometry to detection of peripheral neuropathy in type 1 diabetes mellitus compared with nerve conduction studies. The aim was to assess the use of multi-frequency vibrometry (MFV) in detecting diabetic peripheral neuropathy (DPN) in type 1 diabetes in comparison to nerve conduction studies (NCS) and neurothesiometer (NT). Our objectives were

Single-cell transcriptome analysis reveals distinct cell populations in dorsal root ganglia and their potential roles in diabetic peripheral neuropathy. Diabetic peripheral neuropathy (DPN) is a common complication associated with diabetes, and can affect quality of life considerably. Dorsal root ganglion (DRG) plays an important role in the development of DPN. However, the relationship between

The relationship between dietary phosphorus and peripheral neuropathy in the general population of the United States: A preliminary research. Dietary phosphorus intake may serve as a potential predictor for peripheral neuropathy (PN). While past research has predominantly focused on the relationship between dietary phosphorus and bone health, relatively little is known about its role

Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled Trials Chemotherapy-induced peripheral neuropathy (CIPN) still lacks efficient therapeutic drugs. This study aimed to systematically evaluate the effects of Huangqi Guizhi Wuwu Decoction (HGWD) alone

Prevalence and factors associated with peripheral neuropathy in a setting of retail pharmacies in Malaysia-A cross-sectional study. Peripheral neuropathy is a common cause for neurological consultation, especially among those with diabetes mellitus. However, research on peripheral neuropathy among the general population is lacking in Malaysia. This study aimed to determine the prevalence and factors associated with peripheral neuropathy in a setting of retail pharmacies. This cross-sectional study of 1283 participants was conducted at retail pharmacies in Selangor. Peripheral neuropathy was defined as the final score in the mild to severe category in the severity rating scale using a biothesiometer. SPSS version 26 was used to perform the analysis. Multiple logistic regressions were used

Pattern, causes and functional outcome of peripheral neuropathies in the Amazon region. Peripheral neuropathies have a wide variety of causes and pathophysiologies. Assuming that there are local particularities in the Amazon region, the aim of this study was to describe the characteristics of patients by determining the factors associated with functional severity. This was a retrospective observational study at Cayenne Hospital between January 2015 and May 2023. We included patients from the French hospital activity monitoring database "Programme de médicalisation des systèmes d'information" by searching for the keywords "neuropathy" "Guillain-Barre syndrome"(GBS) "multineuritis" "polyneuritis". The Peripheral Neuropathy Disability (PND) score was determined to quantify the functional severity

Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China. The study aimed to assess the prevalence and risk factors of painful diabetic peripheral neuropathy (PDPN) in patients with type 2 diabetes mellitus (T2DM) and diabetic peripheral neuropathy (DPN) in mainland China

Acupuncture in diabetic peripheral neuropathy-neurological outcomes of the randomized acupuncture in diabetic peripheral neuropathy trial. Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus and can lead to serious complications. Therapeutic strategies for pain control are available but there are few approaches that influence neurological deficits such as numbness

Effects of CXCR1/2 Blockade with Ladarixin on Streptozotocin-Induced Type 1 Diabetes Mellitus and Peripheral Neuropathy and Retinopathy in Rat. The CXC motif chemokine ligand 8 (CXCL8)-CXC motif chemokine receptor 1/2 (CXCR1/2) axis has been implicated in type 1 diabetes mellitus (T1DM). Its actions on non-immune cells may also contribute to T1DM-associated complications, including painful diabetic peripheral neuropathy (DPN) and diabetic retinopathy (DR). We assessed the efficacy of early (4-8 weeks) or late (8-12 weeks) daily ladarixin (LDX) for the treatment of streptozotocin (STZ)-induced T1DM and the related complications of DPN or DR in male rats. Early LDX mitigated STZ-induced dysmetabolism (i.e., blood glucose, insulin), inflammation in dorsal root ganglion/ sciatic nerve

A Retrospective Cohort Study on the Preliminary Efficacy of Massage Therapy for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients. Chemotherapy-induced peripheral neuropathy (CIPN) worsens the quality of life for people with cancer. Massage therapy involves neuromuscular modulations and can potentially reduce CIPN symptoms. We examined the immediate improvements in CIPN-related

A Novel Missense Mutation in SLC12A6 Impairs Ion Transport Function of the Protein to Cause Agenesis of the Corpus Callosum With Peripheral Neuropathy. Agenesis of the corpus callosum with peripheral neuropathy (ACCPN) is a rare autosomal recessive disorder characterized by malformation or absence of the corpus callosum, accompanied by progressive peripheral nerve degeneration. ACCPN